Incidence of venous thromboembolism in COPD: Linking inflammation and thrombosis?

European Respiratory Journal

Volumn 47, Issue 2, 2016, Pages 369-373

  Lankeit, Mareike ^a   Held, Matthias ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Medical Mission Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INCIDENCE; INFLAMMATION; PULMONARY EMBOLISM; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

HUMANS; INCIDENCE; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84958087969     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01679-2015     Document Type: Review

References (30)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD): update 2014. Available from www.goldcopd.org Date last accessed: October 14, 2015.
3. Shapira-Rootman M, Beckerman M, Soimu U, et al. The prevalence of pulmonary embolism among patients suffering from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol 2015; 22: 257-260.
4. Bahloul M, Chaari A, Tounsi A, et al. Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases. Clin Respir J 2015; 9: 270-277.
5. Akpinar EE, Hoşgün D, Akpinar S, et al. Incidence of pulmonary embolism during COPD exacerbation. J Bras Pneumol 2014; 40: 38-45.
6. Choi KJ, Cha SI, Shin KM, et al. Prevalence and predictors of pulmonary embolism in Korean patients with exacerbation of chronic obstructive pulmonary disease. Respiration 2013; 85: 203-209.
7. Ristić L, Rančić M, Radović M, et al. Pulmonary embolism in chronic hypoxemic patients with and without secondary polycythemia-analysis of risk factors in prospective clinical study. Med Glas (Zenica) 2013; 10: 258-265.
8. Dutt TS, Udwadia ZF. Prevalence of venous thromboembolism in acute exacerbations of chronic obstructive pulmonary disease: an Indian perspective. Indian J Chest Dis Allied Sci 2011; 53: 207-210.
9. Gunen H, Gulbas G, In E, et al. Venous thromboemboli and exacerbations of COPD. Eur Respir J 2010; 35: 1243-1248.
10. Rutschmann OT, Cornuz J, Poletti PA, et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax 2007; 62: 121-125.
11. Tillie-Leblond I, Marquette CH, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006; 144: 390-396.
12. Akgun M, Meral M, Onbas O, et al. Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism. Respiration 2006; 73: 428-433.
13. Stein PD, Beemath A, Meyers FA, et al. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med (Hagerstown) 2007; 8: 253-257.
14. Torres-Macho J, Mancebo-Plaza AB, Crespo-Giménez A, et al. Clinical features of patients inappropriately undiagnosed of pulmonary embolism. Am J Emerg Med 2013; 31: 1646-1650.
15. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost 2014; 12: 1580-1590.
16. Børvik T, Brækkan SK, Enga K, et al. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J 2016; 47: 473-481.
17. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 370-372.
18. Cohen AT, Agnelli G, Anderson FA, et al. E Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
19. Konstantinides SV, Torbicki A, Agnelli G, et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033-3069.
20. Tichelaar YI, Kluin-Nelemans HJ, Meijer K. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost 2012; 107: 827-837.
21. Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 2012; 18: 1478-1493.
22. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65: 930-936.
23. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007; 131: 1557-1566.
24. Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 71-77.
25. Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 2010; 25: 253-260.
26. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
27. Chen WJ, Lin CC, Lin CY, et al. Pulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort study. COPD 2014; 11: 438-443.
28. Chung WS, Lin CL, Ho FM, et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J 2014; 43: 801-807.
29. Konstantinides SV. Asthma and pulmonary embolism: bringing airways and vessels closer together. Eur Respir J 2014; 43: 694-696.
30. Majoor CJ, Kamphuisen PW, Zwinderman AH, et al. Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J 2013; 42: 655-661.